Trial of Microplasmin Intravitreal Injection for Non-surgical Treatment of Focal Vitreomacular Adhesion. The MIVI-TRUST (TG-MV-006) Trial.

NCT00781859 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

326

Enrollment

INDUSTRY

Sponsor class

Conditions

Vitreomacular Adhesion

Interventions

DRUG: 125 µg Ocriplasmin
DRUG: Placebo

Sponsor

ThromboGenics